scispace - formally typeset
C

Christopher E. Rudd

Researcher at Université de Montréal

Publications -  194
Citations -  13790

Christopher E. Rudd is an academic researcher from Université de Montréal. The author has contributed to research in topics: T cell & T-cell receptor. The author has an hindex of 61, co-authored 178 publications receiving 12771 citations. Previous affiliations of Christopher E. Rudd include Hôpital Maisonneuve-Rosemont & Imperial College London.

Papers
More filters
Journal ArticleDOI

CD28 and CTLA-4 coreceptor expression and signal transduction.

TL;DR: The current knowledge of the CD28 and CTLA‐4 signaling mechanisms [involving phosphatidylinositol 3 kinase (PI3K), growth factor receptor‐bound protein 2 (Grb2), Filamin A, protein kinase C θ (PKCθ), and phosphatases] that control T‐cell immunity are outlined.
Journal ArticleDOI

The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes

TL;DR: In this paper, the CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (PTK) of 55-60 kDa, which is expressed specifically in T cells.
Journal ArticleDOI

Reversal of the TCR stop signal by CTLA-4.

TL;DR: It is shown that CTLA-4 increases T cell motility and overrides the T cell receptor (TCR)–induced stop signal required for stable conjugate formation between T cells and antigen-presenting cells, which suggests a fundamentally different model of reverse stop signaling.
Journal ArticleDOI

The CD28-Related Molecule ICOS Is Required for Effective T Cell–Dependent Immune Responses

TL;DR: It is suggested that ICOS, the third member of the CD28/CTLA-4 family, plays an important role in production of IL-2, IL-4, IL5, and IFNgamma from recently activated T cells and contributes to T cell-dependent B help in vivo.